Apis Capital Advisors’s Viking Therapeutics VKTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-116,506
Closed -$3.09M 65
2025
Q2
$3.09M Buy
116,506
+4,506
+4% +$119K 1.1% 23
2025
Q1
$2.7M Buy
112,000
+16,000
+17% +$506K 1.31% 23
2024
Q4
$3.86M Buy
96,000
+19,000
+25% +$1.08M 2.57% 12
2024
Q3
$4.87M Sell
77,000
-23,000
-23% -$1.35M 3.39% 9
2024
Q2
$5.3M Buy
100,000
+30,000
+43% +$1.97M 3.91% 9
2024
Q1
$5.74M Sell
70,000
-20,000
-22% -$890K 4.36% 5
2023
Q4
$1.67M Sell
90,000
-58,000
-39% -$759K 1.76% 20
2023
Q3
$1.64M Buy
+148,000
New +$2.12M 2.12% 11
2019
Q3
$619K Sell
90,000
-43,000
-32% -$319K 0.97% 22
2019
Q2
$1.1M Sell
133,000
-17,000
-11% -$145K 1.65% 17
2019
Q1
$1.49M Buy
150,000
+30,000
+25% +$251K 1.85% 12
2018
Q4
$918K Buy
+120,000
New +$1.43M 1.23% 20

Other funds holding VKTX